about
Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral functionGroup II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic DrugsDysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjectsAntipsychotic-induced Hdac2 transcription via NF-κB leads to synaptic and cognitive side effects.Thiophene/thiazole-benzene replacement on guanidine derivatives targeting α2-Adrenoceptors.Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment.Guanidine-based α2-adrenoceptor ligands: Towards selective antagonist activity.Antidepressant-like properties of three new α2-adrenoceptor antagonists.α2-adrenoceptor antagonists: synthesis, pharmacological evaluation, and molecular modeling investigation of pyridinoguanidine, pyridino-2-aminoimidazoline and their derivatives.The endocannabinoid system in mental disorders: Evidence from human brain studiesCorrection to α2-Adrenoceptor Antagonists: Synthesis, Pharmacological Evaluation, and Molecular Modeling Investigation of Pyridinoguanidine, Pyridino-2-aminoimidazoline and Their DerivativesThe motivation for exercise over palatable food is dictated by cannabinoid type-1 receptorsBicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer's DiseaseSerotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased agonism via Gαi1-proteinsLong-term hippocampal interneuronopathy drives sex-dimorphic spatial memory impairment induced by prenatal THC exposureEndocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophrenia
P50
Q24594672-04E5096D-F635-414A-AAD2-9A8A6EF762D0Q26744729-5AFE5313-F278-4414-998A-A7C081394BB0Q36652159-83188C85-E47A-48E3-8AE0-1681856655E3Q45064849-732C84D0-E8A1-4AA4-88A5-D97DA070E968Q47685728-60C85C7B-D07E-42C6-858D-CCB9C1A3D136Q48227373-F2659D31-03EE-42C1-ACC8-EC725843C1FDQ48278070-98F33E7F-BDB4-426A-83A8-8CD0FCA62C3DQ48375448-461AC154-6B19-4EA7-87ED-0DB56A687F72Q48418800-1428C81D-3A88-4E32-872E-D3465A43CE24Q57647117-109764BE-7E1D-4B88-A82A-35FF02707A5DQ60727883-7DAD76A6-67D3-452F-9E9B-0A53BFDA49B5Q64122226-2D50935E-3DC4-4615-A769-3DE8DDE2BE8EQ90159201-35ECF3E9-A304-4559-9753-95E3A916EC8EQ91306949-B580DFBB-E52D-46A3-9D7F-38096138A073Q92946292-971F9641-F485-4818-B049-64EA7C9CE439Q93008942-211FFF07-D909-46FF-B8D4-C4BC05053A11
P50
description
researcher ORCID ID = 0000-0002-0477-5757
@en
wetenschapper
@nl
name
Carolina Muguruza
@ast
Carolina Muguruza
@en
Carolina Muguruza
@es
Carolina Muguruza
@nl
type
label
Carolina Muguruza
@ast
Carolina Muguruza
@en
Carolina Muguruza
@es
Carolina Muguruza
@nl
prefLabel
Carolina Muguruza
@ast
Carolina Muguruza
@en
Carolina Muguruza
@es
Carolina Muguruza
@nl
P106
P1153
55484859100
P21
P31
P496
0000-0002-0477-5757